F86S (p.Phe86Ser) variant of APOH (Beta-2-glycoprotein 1)

F86S (p.Phe86Ser) in APOH (Beta-2-glycoprotein 1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not specified. The available variant effect predictions contribute to a CATVariant prioritization score of 0.40 / 1. The record also includes population frequency data and structural context.

F86S (p.Phe86Ser) variant details